Considering that BCL6 is widely involved in the progression of NAFLD as well as the fact that fatty liver previously demonstrates markedly reduced BCL6 expression, we speculate that aberrant BCL6 expression may have an important influence on NAFLD. This evidence concerns the gene BCL6 and metabolic dysfunction-associated steatotic liver disease.